Beth Israel Deaconess Medical Center, Boston
TIMI frame count improved after percutaneous coronary intervention
Published in Cardiovascular Device Liability Week, September 26th, 2004
"We hypothesized that blood flow in noninfarct arteries would improve after percutaneous coronary intervention of the culprit artery in the setting of ST-elevation myocardial infarction (STEMI)," wrote G.S. Gardner and colleagues of the Beth Israel Deaconess Medical Center in Boston.
The researchers explained, "The corrected thrombolysis-in-myocardial-infarction (TIMI) frame count was measured in 94 patients (102 arteries) enrolled in the INTEGRITI, ENTIRE,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Cardiac Science, Inc.
$3.7M AED orders placed from Nihon Kohden in Japan - CHI, Creteil
Airway dysfunction syndrome caused by fire extinguishers - LifeCord Inc.
Cryopreserved cord blood fractions alternative source of mesenchymal stem cells - Medical Surgical Center of Europe, Le Port Marly
A transradial approach for diagnostic angiography is evaluated - Transplant Medicine
Woman says U.S. government blocking transplant - University of Texas
Organized healthcare delivery in Texas prison system improves health outcomes - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
